论文部分内容阅读
目的 探讨肝癌经皮肝动脉栓塞术 (TAE)的疗效与碘油乙醇乳剂用量的相关性 ,进一步提高TAE在肝癌治疗中的疗效。材料与方法 3 5例肝癌患者 ,分成两组。第一组 17例 ,按肿瘤直径与碘油乙醇乳剂剂量等比例行TAE治疗 ;第二组 18例 ,按碘油乙醇乳剂最大剂量法进行治疗 ,并进行对比分析。结果 第一组和第二组 1、2年生存率分别为 5 8.82 %、2 3 .5 3 %和 77.78%、44.44% (P <0 .0 5 )。结论 对于适合TAE的肝癌患者 ,肝癌TAE疗效与碘油乙醇乳剂用量成明显正相关。
Objective To investigate the correlation between the efficacy of percutaneous transcatheter hepatic artery embolization (TAE) and the amount of lipiodol ethanol emulsion in liver cancer, and further improve the efficacy of TAE in the treatment of liver cancer. Materials and Methods 35 patients with liver cancer were divided into two groups. In the first group, 17 cases were treated with TAE according to the tumor diameter and the dose of lipiodol-ethanol emulsion; the second group was treated with the maximum dose of ethanol emulsion in the second group, and a comparative analysis was performed. Results The 1-year and 2-year survival rates for the first and second groups were 5 8.82%, 23.35 percent, 77.78%, and 44.44%, respectively (P < 0.05). Conclusion For TAE-adapted liver cancer patients, the efficacy of TAE in liver cancer is positively correlated with the amount of lipiodol ethanol emulsion.